Home » Topics » Conferences

Conferences
RSS

Grelan characterizes candidate for diabetic complications

March 20, 1997

Eisai discovers novel selective PDE I inhibitor

March 19, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

March 19, 1997

Reduced risk of mortality found for losartan in ELITE study

March 19, 1997

Cardioprotective effects of KBR-9032

March 19, 1997

Gastric prokinetic agent developed by Kyorin

March 19, 1997

InTIME trial indicates nPA superior to tPA in MI

March 19, 1997

Alternative to bypass surgery presented at ACC meeting

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...